Rang	Name	Position
1	Mr. Daniel R. Faga	President, CEO & Director
2	Mr. Christopher M. Murphy	Chief Financial Officer
3	Ms. Beth Mueller	Senior Vice President of Human Resources
4	Dr. Martin Dahl Ph.D.	Senior Vice President of Research
5	Mr. Benjamin Stone	Chief Business Officer
6	Ms. Monique Da Silva	Senior Vice President of Corporate Affairs
7	Ms. Priya Raina	Senior Vice President of Clinical Operations
8	Ms. Cailin Sibley FACR, M.D.	Senior Vice President of Translational Medicine
9	John Kwon	Vice President of GI Clinical Development

Aufteilung der Investoren

Rang	Inhaber	Anteile	Wert
1	EcoR1 Capital, LLC	26,61%	0,43 Mrd. USD
2	BlackRock Inc	5,68%	0,09 Mrd. USD
3	TANG CAPITAL MANAGEMENT LLC	4,49%	0,07 Mrd. USD
4	Morgan Stanley - Brokerage Accounts	3,36%	0,05 Mrd. USD
5	State Street Corp	3,35%	0,05 Mrd. USD
6	Vanguard Capital Management, LLC	2,88%	0,05 Mrd. USD
7	Affinity Asset Advisors, LLC	2,79%	0,05 Mrd. USD
8	Sanofi	2,78%	0,04 Mrd. USD
9	Millennium Management LLC	2,73%	0,04 Mrd. USD
10	683 Capital Management LLC	2,11%	0,03 Mrd. USD
11	Palo Alto Investors, LLC	2,04%	0,03 Mrd. USD
12	First Light Asset Management, LLC	1,97%	0,03 Mrd. USD
13	D. E. Shaw & Co LP	1,82%	0,03 Mrd. USD
14	Geode Capital Management, LLC	1,76%	0,03 Mrd. USD
15	Vanguard Portfolio Management, LLC	1,76%	0,03 Mrd. USD
16	Bank of America Corp	1,69%	0,03 Mrd. USD
17	Arrowstreet Capital Limited Partnership	1,66%	0,03 Mrd. USD
18	FMR Inc	1,60%	0,03 Mrd. USD
19	Citadel Advisors Llc	1,33%	0,02 Mrd. USD
20	Federated Hermes Inc	1,32%	0,02 Mrd. USD